Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Dr Shang-Kuan (Steven) Lin

Dr Shang-Kuan (Steven) Lin

Shang-Kuan Lin

DPhil


Postdoctoral Researcher

Shang-Kuan (Steven) Lin is currently a postdoctoral researcher in Professor Aiden Doherty's group at the University of Oxford, funded by Novo Nordisk. The group specialises in using accelerometer data to derive epidemiological and genomic research. Steven’s current research focuses on linking genomics, human behavior, and disease outcomes.

Steven completed his DPhil in Genomic Medicine and Statistics at the University of Oxford in 2022. His research during the DPhil concentrated on the genomic study of infectious diseases, examining both the human host and the pathogen.